These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16996140)

  • 1. Prediction of treatment response in major depression: integration of concepts.
    Mulert C; Juckel G; Brunnmeier M; Karch S; Leicht G; Mergl R; Möller HJ; Hegerl U; Pogarell O
    J Affect Disord; 2007 Mar; 98(3):215-25. PubMed ID: 16996140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loudness dependence of the auditory evoked potential and response to antidepressants in Chinese patients with major depression.
    Lee TW; Yu YW; Chen TJ; Tsai SJ
    J Psychiatry Neurosci; 2005 May; 30(3):202-5. PubMed ID: 15944745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intensity dependence of auditory evoked ERP components predicts responsiveness to reboxetine treatment in major depression.
    Linka T; Müller BW; Bender S; Sartory G; Gastpar M
    Pharmacopsychiatry; 2005 May; 38(3):139-43. PubMed ID: 15902586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder.
    Juckel G; Pogarell O; Augustin H; Mulert C; Müller-Siecheneder F; Frodl T; Mavrogiorgou P; Hegerl U
    J Clin Psychiatry; 2007 Aug; 68(8):1206-12. PubMed ID: 17854244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frontal and rostral anterior cingulate (rACC) theta EEG in depression: implications for treatment outcome?
    Arns M; Etkin A; Hegerl U; Williams LM; DeBattista C; Palmer DM; Fitzgerald PB; Harris A; deBeuss R; Gordon E
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1190-200. PubMed ID: 25936227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The intensity dependence of the auditory evoked N1 component as a predictor of response to Citalopram treatment in patients with major depression.
    Linka T; Müller BW; Bender S; Sartory G
    Neurosci Lett; 2004 Sep; 367(3):375-8. PubMed ID: 15337269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response-dependent differences in regional cerebral blood flow changes with citalopram in treatment of major depression.
    Joe AY; Tielmann T; Bucerius J; Reinhardt MJ; Palmedo H; Maier W; Biersack HJ; Zobel A
    J Nucl Med; 2006 Aug; 47(8):1319-25. PubMed ID: 16883012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-treatment anterior cingulate activity as a predictor of antidepressant response to repetitive transcranial magnetic stimulation (rTMS).
    Langguth B; Wiegand R; Kharraz A; Landgrebe M; Marienhagen J; Frick U; Hajak G; Eichhammer P
    Neuro Endocrinol Lett; 2007 Oct; 28(5):633-8. PubMed ID: 17984932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The loudness dependence of the auditory evoked potential (LDAEP) in schizophrenia, bipolar disorder, major depressive disorder, anxiety disorder, and healthy controls.
    Park YM; Lee SH; Kim S; Bae SM
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):313-6. PubMed ID: 20005279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loudness dependence of primary auditory-cortex-evoked activity as predictor of therapeutic outcome to prophylactic lithium treatment in affective disorders--a retrospective study.
    Juckel G; Mavrogiorgou P; Bredemeier S; Gallinat J; Frodl T; Schulz C; Möller HJ; Hegerl U
    Pharmacopsychiatry; 2004 Mar; 37(2):46-51. PubMed ID: 15048610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of intensity dependence of the auditory evoked potential (IDAEP) in medicated melancholic and non-melancholic depression.
    Fitzgerald PB; Mellow TB; Hoy KE; Segrave R; Cooper NR; Upton DJ; Croft RJ
    J Affect Disord; 2009 Oct; 117(3):212-6. PubMed ID: 19201033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of citalopram treatment on hypothermic and hormonal responses to the 5-HT1A receptor agonist buspirone in patients with major depression and therapeutic response.
    Navinés R; Martín-Santos R; Gómez-Gil E; Martínez de Osaba MJ; Imaz ML; Gastó C
    Psychoneuroendocrinology; 2007 May; 32(4):411-6. PubMed ID: 17337123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
    Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining relations between alpha power as well as anterior cingulate cortex-localized theta activity and response to single or dual antidepressant pharmacotherapies.
    Jaworska N; Blondeau C; Tessier P; Norris S; Fusee W; Blier P; Knott V
    J Psychopharmacol; 2014 Jun; 28(6):587-95. PubMed ID: 24557661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escitalopram/reboxetine combination in depressed patients with substance use disorder.
    Camarasa X; Lopez-Martinez E; Duboc A; Khazaal Y; Zullino DF
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):165-8. PubMed ID: 15610962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression.
    Baune BT; Caliskan S; Todder D
    Hum Psychopharmacol; 2007 Jan; 22(1):1-9. PubMed ID: 17191266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pindolol does not augment central serotonin function increases to citalopram in humans: an auditory evoked potential investigation.
    Segrave R; Croft RJ; Illic S; Phan KL; Nathan PJ
    Pharmacol Biochem Behav; 2006 Sep; 85(1):82-90. PubMed ID: 16904172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment Rostral Anterior Cingulate Cortex Theta Activity in Relation to Symptom Improvement in Depression: A Randomized Clinical Trial.
    Pizzagalli DA; Webb CA; Dillon DG; Tenke CE; Kayser J; Goer F; Fava M; McGrath P; Weissman M; Parsey R; Adams P; Trombello J; Cooper C; Deldin P; Oquendo MA; McInnis MG; Carmody T; Bruder G; Trivedi MH
    JAMA Psychiatry; 2018 Jun; 75(6):547-554. PubMed ID: 29641834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.